FDA data Registry peer set 4 peers

Alternatives to darifenacin

4 same-class SPL records vs darifenacin - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Enablex

Anticholinergic (Overactive Bladder) Prescription 4 alternatives found

About darifenacin

Darifenacin (Enablex) is a medicine that helps control an overactive bladder. It reduces the feeling of needing to go to the bathroom so often.

Used for: This medicine treats overactive bladder. If you have overactive bladder, you may feel a sudden need to urinate. You may also urinate more often than normal, or leak urine.

4 Anticholinergic (Overactive Bladder) peers (wide set)

Compare darifenacin vs fesoterodine side-by-side →

darifenacin vs fesoterodine & solifenacin · FAERS reaction fields

FAERS top-reaction field "Peripheral Swelling" shows the widest count spread between darifenacin and fesoterodine, solifenacin, tolterodine in this extract (91-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect darifenacin fesoterodinesolifenacintolterodine
Peripheral Swelling 91 - - -
Herpes Zoster 83 - - -
Pneumonia Viral 79 - - -
Anaemia 59 - - -
Arthralgia 59 - - -
Oral Pain 57 - - -
Arthritis 56 - - -
Blood Cholesterol Increased 54 - - -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

darifenacin peer mix vs class inventory

Peer mix

0 OTC and 4 Rx SPL records in this peer set (4 total). Class inventory for Anticholinergic (Overactive Bladder): 5 drugs.

Frequently Asked Questions

What same-class SPL records sit beside darifenacin?
This registry lists 4 Anticholinergic (Overactive Bladder) medication records beside darifenacin, including fesoterodine, solifenacin, tolterodine, and more. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Anticholinergic (Overactive Bladder) peer set (4 records)

darifenacin (Enablex) sits in a wide Anticholinergic (Overactive Bladder) peer set (4 of 4 class peers shown). Labeled indication field for darifenacin: This medicine treats overactive bladder.

Top FAERS reaction fields for darifenacin total 646 reports across 10 reactions, set beside fesoterodine, solifenacin, tolterodine. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full darifenacin profile →

Field note for darifenacin: see also the generic vs brand label guide when reading Enablex SPL strings.